Health Care [ 9/12 ] | Pharmaceuticals [ 38/74 ]
NASDAQ | Common Stock
MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders.
The company holds exclusiveU. S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder.
In addition, its oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is based in Miami, Florida.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Dec 3, 25 | -0.07 Increased by +51.29% | -0.09 Increased by +24.22% |
| Sep 3, 25 | -0.09 Increased by +18.18% | -0.10 Increased by +10.00% |
| May 28, 25 | -0.11 Increased by +8.33% | -0.16 Increased by +31.25% |
| Feb 26, 25 | -0.17 Increased by +52.70% | -0.13 Decreased by -34.62% |
| Nov 27, 24 | -0.14 Increased by +46.15% | -0.11 Decreased by -27.27% |
| Aug 28, 24 | -0.11 Decreased by -10.00% | -0.12 Increased by +8.33% |
| May 13, 24 | -0.12 | -0.10 Decreased by -20.00% |
| Feb 28, 24 | -0.37 | -0.23 Decreased by -60.87% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 25 | 0.00 Decreased by N/A% | -22.69 M Decreased by -1.01 K% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 25 | 0.00 Decreased by N/A% | -1.54 M Increased by +9.08% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 25 | 11.16 M Increased by +N/A% | -1.78 M Decreased by -3.84% | Decreased by -15.98% Decreased by N/A% |
| Dec 31, 24 | 0.00 Decreased by N/A% | -2.40 M Increased by +58.54% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 24 | 0.00 Decreased by N/A% | -2.04 M Increased by +43.03% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by N/A% | -1.69 M Decreased by -33.58% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 24 | 0.00 Decreased by N/A% | -1.72 M Decreased by -28.09% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 23 | 0.00 Decreased by N/A% | -5.79 M Decreased by -328.86% | Decreased by N/A% Decreased by N/A% |